Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03553108” into
the search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D0816C00024” into the search box, and click “Find a Study”.
Full Trial Title: A Phase 1, Randomised, Open-label, 4-Period Crossover Study to
Develop an In Vitro-In Vivo Correlation for Olaparib Tablets in Subjects with Solid
Tumors.
National Clinical Trials number: NCT03553108
AstraZeneca AB Protocol Number: D0816C00024
AstraZeneca AB sponsored this study and has its headquarters in Södertälje,
Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 0.10 2020_05_20 8